(Q44227516)

English

Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 December 2017

Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease (English)

1 reference

Europe PubMed Central

1 December 2017

0 references

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

1 December 2017

author name string

FLIP Pathology Consortium

2

1 reference

Europe PubMed Central

1 December 2017

language of work or name

0 references

publication date

26 June 2014

1 reference

Europe PubMed Central

1 December 2017

1 reference

Europe PubMed Central

1 December 2017

60

1 reference

Europe PubMed Central

1 December 2017

2

1 reference

Europe PubMed Central

1 December 2017

565-575

1 reference

Europe PubMed Central

1 December 2017

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Long-term follow-up of patients with NAFLD and elevated liver enzymes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Endpoints and clinical trial design for nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

NAFLD fibrosis score: is it ready for wider use in clinical practice and for clinical trials?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Nonalcoholic fatty liver disease: pathology and pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Hepatic histology in obese patients undergoing bariatric surgery

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Sources of variability in histological scoring of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Sampling variability of liver fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Introduction of virtual microscopy in routine surgical pathology--a hypothesis and personal view from Europe

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

21 January 2018

Fatty liver hepatitis and cirrhosis in obese patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

7 January 2021

based on heuristic

inferred from DOI database lookup

Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

7 January 2021

based on heuristic

inferred from DOI database lookup

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathology of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27173

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.27173

1 reference

Europe PubMed Central

1 December 2017

1 reference

Europe PubMed Central

1 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44227516&oldid=2108745665"